Chen; Chiung-Tong
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chen; Chiung-Tong.The latest application filed is for "poly heterocyclic conjugates and their pharmaceutical uses".
- Chen; Chiung-Tong - Miaoli County TW
- Chen; Chiung-Tong - Taipei TW
- Chen; Chiung-Tong - Taipei City TW
- Chen; Chiung-Tong - Zhunan TW
- Chen; Chiung-Tong - Zhunan Town TW
| Patent | Date |
|---|---|
| Poly Heterocyclic Conjugates And Their Pharmaceutical Uses App 20210403483 - Tsou; Lun Kelvin ; et al. | 2021-12-30 |
| Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease Grant 10,584,120 - Chen , et al. | 2020-03-10 |
| Benzimidazole Compounds And Use Thereof For Treating Alzheimer's Disease Or Huntington's Disease App 20200071312 - Chen; Chih-Hao ; et al. | 2020-03-05 |
| Heterocyclic compounds and use thereof Grant 9,926,298 - Shia , et al. March 27, 2 | 2018-03-27 |
| Heterocyclic Compounds And Use Thereof App 20180009786 - Shia; Kak-Shan ; et al. | 2018-01-11 |
| Heterocyclic compounds and use thereof Grant 9,862,703 - Shia , et al. January 9, 2 | 2018-01-09 |
| Dipicolylamine derivatives and their pharmaceutical uses Grant 9,388,193 - Chen , et al. July 12, 2 | 2016-07-12 |
| Heterocyclic Compounds And Use Thereof App 20160083369 - Shia; Kak-Shan ; et al. | 2016-03-24 |
| Formulations of indol-3-yl-2-oxoacetamide compounds Grant 8,026,271 - Yeh , et al. September 27, 2 | 2011-09-27 |
| Methods of 1H-indol-3-yl-2-oxoacetamide compounds Grant 7,662,834 - Chen , et al. February 16, 2 | 2010-02-16 |
| Anticancer Oral Formulation App 20100010059 - Yeh; Teng-Kuang ; et al. | 2010-01-14 |
| Imidazolamino compounds Grant 7,569,596 - Chen , et al. August 4, 2 | 2009-08-04 |
| Genes relating to gastric cancer metastasis App 20090111109 - Tuan; Tsung-Fan ; et al. | 2009-04-30 |
| Imidazolidinone compounds Grant 7,501,445 - Chern , et al. March 10, 2 | 2009-03-10 |
| Imidazolamino compounds Grant 7,462,723 - Chen , et al. December 9, 2 | 2008-12-09 |
| Novel Compounds And Methods Of Use Thereof App 20080242701 - Chen; Chiung-Tong ; et al. | 2008-10-02 |
| Use of 1H-indol-3-yl-2-oxoacetamide compounds Grant 7,396,838 - Chen , et al. July 8, 2 | 2008-07-08 |
| Imidazolidinone compounds App 20070049623 - Chern; Jyh-Haur ; et al. | 2007-03-01 |
| Imidazolamino compounds App 20060264462 - Chen; Chiung-Tong ; et al. | 2006-11-23 |
| Imidazolamino compounds App 20060264461 - Chen; Chiung-Tong ; et al. | 2006-11-23 |
| Imidazolidinone compounds Grant 7,129,359 - Chern , et al. October 31, 2 | 2006-10-31 |
| Imidazolamino compounds App 20060241140 - Chen; Chiung-Tong ; et al. | 2006-10-26 |
| Imidazolamino compounds Grant 7,109,227 - Chen , et al. September 19, 2 | 2006-09-19 |
| Novel compounds and methods of use thereof App 20050234098 - Chen, Chiung-Tong ; et al. | 2005-10-20 |
| Indol-3-YL-2-oxoacetamide compounds and methods of use thereof Grant 6,903,104 - Chen , et al. June 7, 2 | 2005-06-07 |
| Imidazolamino compounds App 20040157883 - Chen, Chiung-Tong ; et al. | 2004-08-12 |
| Imidazolidinone compounds App 20040116476 - Chern, Jyh-Haur ; et al. | 2004-06-17 |
| Novel compounds and methods of use thereof App 20030181482 - Chen, Chiung-Tong ; et al. | 2003-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 